| P50 | author | Pier Luigi Zinzani | Q56098967 |
| P2093 | author name string | Pier Paolo Piccaluga | |
| P2860 | cites work | Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma | Q24672476 |
| | MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas | Q28214707 |
| | A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project | Q28239256 |
| | A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group | Q28246957 |
| | Report of the Committee on Hodgkin's Disease Staging Classification | Q28250452 |
| | A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project | Q28251216 |
| | New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project | Q28279668 |
| | Assignment of the T-cell differentiation gene MAL to human chromosome 2, region cen----q13 | Q28293989 |
| | Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma | Q28297805 |
| | Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy | Q32063712 |
| | Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation | Q33236181 |
| | Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. | Q33632062 |
| | CNS involvement in primary mediastinal large B-cell lymphoma | Q33773359 |
| | The role of lipid rafts in signalling and membrane trafficking in T lymphocytes | Q34460939 |
| | Mediastinal (thymic) large B-cell lymphoma: where do we stand? | Q34688561 |
| | Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins | Q35036705 |
| | Molecular characterization of primary mediastinal B cell lymphoma | Q35773944 |
| | Discordant expression of immunoglobulin and its associated molecule mb-1/CD79a is frequently found in mediastinal large B cell lymphomas. | Q35794900 |
| | Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999. | Q36237659 |
| | Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B. | Q36694393 |
| | Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients | Q36695611 |
| | Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH). | Q40087598 |
| | NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes | Q40427138 |
| | Downregulation of internal enhancer activity contributes to abnormally low immunoglobulin expression in the MedB-1 mediastinal B-cell lymphoma cell line. | Q40463591 |
| | Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line | Q40486172 |
| | Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma. | Q40573622 |
| | Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas | Q40604292 |
| | Primary mediastinal large cell lymphoma | Q40655994 |
| | Isotype-switched immunoglobulin genes with a high load of somatic hypermutation and lack of ongoing mutational activity are prevalent in mediastinal B-cell lymphoma | Q40772895 |
| | Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line | Q40821711 |
| | MAL, a novel integral membrane protein of human T lymphocytes, associates with glycosylphosphatidylinositol-anchored proteins and Src-like tyrosine kinases | Q40990037 |
| | Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study | Q43254582 |
| | The human thymus contains a novel population of B lymphocytes | Q43410995 |
| | Lipid rafts mediate biosynthetic transport to the T lymphocyte uropod subdomain and are necessary for uropod integrity and function | Q43863946 |
| | Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B cell differentiation | Q43901216 |
| | Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study | Q44266152 |
| | Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience | Q46763721 |
| | AID expression identifies interfollicular large B cells as putative precursors of mature B-cell malignancies. | Q46790535 |
| | Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group. | Q53347810 |
| | Magnetic resonance imaging and 67gallium scan in mediastinal malignant lymphoma: a prospective pilot study. | Q53805583 |
| | The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. | Q53931762 |
| | Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma. | Q55042257 |
| | Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients | Q57004874 |
| | Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patients | Q57011679 |
| | Molecular features of primary mediastinal B-cell lymphoma: involvement of p16INK4A, p53 and c-myc | Q57426191 |
| | Mediastinal B-cell lymphoma: A study of its histomorphologic spectrum based on 109 cases | Q57786661 |
| | Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients | Q57786732 |
| | Gains ofREL in primary mediastinal B-cell lymphoma coincide with nuclear accumulation of REL protein | Q61312181 |
| | Expression of bcl-6 and CD10 in Primary Mediastinal Large B-Cell Lymphoma | Q61596469 |
| | Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients | Q67657715 |
| | Stage II large B-cell lymphoma with sclerosis treated with MACOP-B | Q67711476 |
| | Mediastinal large cell lymphoma. An uncommon subset of adult lymphoma curable with combined modality therapy | Q67927289 |
| | Thymic medullary cells expressing B lymphocyte antigens | Q68098972 |
| | Defective expression of MHC class I antigens is frequent in B-cell lymphomas of high-grade malignancy | Q68162123 |
| | Sequential combination chemotherapy of high-grade non-Hodgkin's lymphoma with 5-fluorouracil, methotrexate, cytosine-arabinoside, cyclophosphamide, doxorubicin, vincristine, and prednisone (F-MACHOP) | Q69394796 |
| | Mediastinal diffuse large-cell lymphoma with sclerosis: a condition with a poor prognosis | Q69768342 |
| | Mediastinal diffuse large-cell lymphoma with sclerosis. A clinicopathologic study of 60 cases | Q70025005 |
| | Primary mediastinal clear cell lymphoma of B-cell type | Q70287010 |
| | Primary non-Hodgkin's lymphoma of the mediastinum | Q70507851 |
| | Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene | Q71017596 |
| | Primary Mediastinal B-cell lymphoma with sclerosis: clinical and therapeutic evaluation of 22 patients | Q71310217 |
| | Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimens | Q71695942 |
| | Primary mediastinal lymphoma in adults | Q71848069 |
| | Primary large-cell lymphoma of the mediastinum | Q72621729 |
| | Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features | Q72621733 |
| | Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients | Q72790352 |
| | The MAL gene is expressed in primary mediastinal large B-cell lymphoma | Q73160449 |
| | Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia | Q73337958 |
| | MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis | Q77565347 |
| | Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging | Q77974747 |
| | CD30 expression is common in mediastinal large B-cell lymphoma | Q78105218 |
| | Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma | Q79467568 |
| | Primary mediastinal large B-cell lymphoma: results of intensive chemotherapy regimens (MACOP-B/VACOP-B) plus involved field radiotherapy on 53 patients. A single institution experience | Q80017604 |
| | CD23 expression in mediastinal large B-cell lymphomas | Q81070836 |
| | Primary mediastinal large cell lymphoma (PMBL): frontline treatment with autologous stem cell transplantation (ASCT). The GEL-TAMO experience | Q81141429 |
| | Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma | Q81349866 |
| | Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study | Q84774064 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 407-415 | |
| P577 | publication date | 2011-10-01 | |
| P1433 | published in | Current Oncology Reports | Q2264969 |
| P1476 | title | Primary mediastinal DLBCL: evolving biologic understanding and therapeutic strategies | |
| P478 | volume | 13 | |